Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Debt / NOTE 2.750% 2/0
-
Number of holders
-
22
-
Total 13F principal, excl. options
-
196M
-
Principal change
-
+7.52M
-
Total reported value, excl. options
-
$162M
-
Value change
-
+$9.01M
-
Number of buys
-
5
-
Number of sells
-
-10
-
Price
-
$0.83
Significant Holders of STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 as of Q4 2017
24 filings reported holding 34385PAA6 - STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 as of Q4 2017.
STANDARD BIOTOOLS INC - NOTE 2.750% 2/0 has 22 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $196M of principal
.
Largest 10 bondholders include Indaba Capital Management, L.P. ($60.8M of principal), Partner Fund Management, L.P. ($30.1M of principal), CITADEL ADVISORS LLC ($16M of principal), FRANKLIN RESOURCES INC ($14.4M of principal), AMERIPRISE FINANCIAL INC ($14.1M of principal), SMH CAPITAL ADVISORS INC ($11.8M of principal), ORBIMED ADVISORS LLC ($10M of principal), SYMPHONY ASSET MANAGEMENT LLC ($9.24M of principal), Invesco Ltd. ($7.06M of principal), and SILVERBACK ASSET MANAGEMENT LLC ($5.99M of principal).
This table shows the top 22 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.